XML 47 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment Reporting (Tables)
 9 Months Ended
Sep. 30, 2018
Segment Reporting [Abstract]  
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(in millions)
2018
 
2017
 
2018
 
2017
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
MedSurg*
$
746

 
$
676

 
$
2,207

 
$
1,997

Rhythm and Neuro*
740

 
689

 
2,252

 
2,057

Cardiovascular
908

 
857

 
2,806

 
2,586

 
$
2,393

 
$
2,222

 
$
7,262

 
$
6,640

 
 
 
 
 
 
 
 
Income (loss) before income taxes
 
 
 
 
 
 
 
MedSurg*
$
274

 
$
248

 
$
807

 
$
707

Rhythm and Neuro*
168

 
126

 
481

 
372

Cardiovascular
268

 
239

 
858

 
733

Operating income allocated to reportable segments
710

 
613

 
2,146

 
1,813

Corporate expenses, including hedging activities
(97
)
 
(55
)
 
(297
)
 
(172
)
Intangible asset impairment charges, acquisition-related, restructuring- and restructuring-related and litigation-related net (charges) credits
(77
)
 
(42
)
 
(225
)
 
(250
)
Amortization expense
(148
)
 
(139
)
 
(437
)
 
(424
)
Operating income (loss)
388

 
377

 
1,187

 
967

Other expense, net
68

 
(68
)
 
(61
)
 
(261
)
Income (loss) before income taxes
$
456

 
$
309

 
$
1,126

 
$
706

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating Income as a Percentage of Segment Net Sales
 
 
 
 
 
 
 
MedSurg*
36.8
%
 
36.7
%
 
36.6
%
 
35.4
%
Rhythm and Neuro*
22.7
%
 
18.3
%
 
21.4
%
 
18.1
%
Cardiovascular
29.5
%
 
27.9
%
 
30.6
%
 
28.3
%